Trial intelligence / Profile preview

Patient Satisfaction After Switching to Jatenzo

NCT04983940Phase 4Completed

Sponsor
University of Miami
Start
Jun 2021
Primary completion
Apr 2023
Modality
Hormone, Biologic
Countries
1
01

Overview

A Phase 4 trial of testosterone undecanoate in testosterone deficiency (TD), sponsored by University of Miami. Started Jun 2021; status: completed.

02

Drugs

testosterone undecanoate
03

Conditions

testosterone deficiency (TD)

Beyond the preview

Go deeper on NCT04983940.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04983940.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call